ForSight spinoff acquired by QLT Inc.

Forsight Newco II Inc., a privately-held spinoff of ForSight Labs LLC, has agreed to be acquired by QLT Inc. (QLTI) for $42 million as well as future milestone payments and royalties on net sales of products.

The acquisition includes rights to a proprietary ocular punctual plug drug delivery system, which may have potential as a treatment for glaucoma.

ForSight Labs LLC, an ophthalmic technology incubator backed by Menlo Park investment firm Morgenthaler Ventures, Split Rock Partners and Versant Ventures, spun off its first company, Transcend Medical Inc., in late 2006.

businessBusiness & Real Estate

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

Sunset supervisor wants to keep Great Highway car free during crisis

Mar eyes empty roadway as ideal space for bicylists and pedestrians

Future uncertain for San Francisco Pride 2020 amid coronavirus

Mayor Breed casts doubt on large-scale gathering being held during crisis

SFUSD: City schools to stay closed for the rest of the year

District joins five other Bay Area districts in announcing closure

Bernie Sanders suspends his presidential campaign

Bernie Sanders on Wednesday suspended an anti-establishment presidential campaign that changed the… Continue reading

Most Read